IBDEI1K1 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24849,2)
 ;;=^5001253
 ;;^UTILITY(U,$J,358.3,24850,0)
 ;;=C50.912^^107^1211^135
 ;;^UTILITY(U,$J,358.3,24850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24850,1,3,0)
 ;;=3^Malig Neop Left Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,24850,1,4,0)
 ;;=4^C50.912
 ;;^UTILITY(U,$J,358.3,24850,2)
 ;;=^5001196
 ;;^UTILITY(U,$J,358.3,24851,0)
 ;;=C50.911^^107^1211^157
 ;;^UTILITY(U,$J,358.3,24851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24851,1,3,0)
 ;;=3^Malig Neop Right Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,24851,1,4,0)
 ;;=4^C50.911
 ;;^UTILITY(U,$J,358.3,24851,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,24852,0)
 ;;=C50.919^^107^1211^127
 ;;^UTILITY(U,$J,358.3,24852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24852,1,3,0)
 ;;=3^Malig Neop Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,24852,1,4,0)
 ;;=4^C50.919
 ;;^UTILITY(U,$J,358.3,24852,2)
 ;;=^5001197
 ;;^UTILITY(U,$J,358.3,24853,0)
 ;;=C62.90^^107^1211^165
 ;;^UTILITY(U,$J,358.3,24853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24853,1,3,0)
 ;;=3^Malig Neop Testis,Unspec
 ;;^UTILITY(U,$J,358.3,24853,1,4,0)
 ;;=4^C62.90
 ;;^UTILITY(U,$J,358.3,24853,2)
 ;;=^5001236
 ;;^UTILITY(U,$J,358.3,24854,0)
 ;;=D03.9^^107^1211^170
 ;;^UTILITY(U,$J,358.3,24854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24854,1,3,0)
 ;;=3^Melanoma in Situ,Unspec
 ;;^UTILITY(U,$J,358.3,24854,1,4,0)
 ;;=4^D03.9
 ;;^UTILITY(U,$J,358.3,24854,2)
 ;;=^5001908
 ;;^UTILITY(U,$J,358.3,24855,0)
 ;;=C45.0^^107^1211^171
 ;;^UTILITY(U,$J,358.3,24855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24855,1,3,0)
 ;;=3^Mesothelioma of Pleura
 ;;^UTILITY(U,$J,358.3,24855,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,24855,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,24856,0)
 ;;=C90.01^^107^1211^173
 ;;^UTILITY(U,$J,358.3,24856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24856,1,3,0)
 ;;=3^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,24856,1,4,0)
 ;;=4^C90.01
 ;;^UTILITY(U,$J,358.3,24856,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,24857,0)
 ;;=C90.00^^107^1211^174
 ;;^UTILITY(U,$J,358.3,24857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24857,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,24857,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,24857,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,24858,0)
 ;;=C94.6^^107^1211^175
 ;;^UTILITY(U,$J,358.3,24858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24858,1,3,0)
 ;;=3^Myelodysplastic Disease NEC
 ;;^UTILITY(U,$J,358.3,24858,1,4,0)
 ;;=4^C94.6
 ;;^UTILITY(U,$J,358.3,24858,2)
 ;;=^5001846
 ;;^UTILITY(U,$J,358.3,24859,0)
 ;;=D61.82^^107^1211^176
 ;;^UTILITY(U,$J,358.3,24859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24859,1,3,0)
 ;;=3^Myelophthisis
 ;;^UTILITY(U,$J,358.3,24859,1,4,0)
 ;;=4^D61.82
 ;;^UTILITY(U,$J,358.3,24859,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,24860,0)
 ;;=D47.9^^107^1211^177
 ;;^UTILITY(U,$J,358.3,24860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24860,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,24860,1,4,0)
 ;;=4^D47.9
 ;;^UTILITY(U,$J,358.3,24860,2)
 ;;=^5002260
 ;;^UTILITY(U,$J,358.3,24861,0)
 ;;=D53.9^^107^1211^181
 ;;^UTILITY(U,$J,358.3,24861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24861,1,3,0)
 ;;=3^Nutritional Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,24861,1,4,0)
 ;;=4^D53.9
 ;;^UTILITY(U,$J,358.3,24861,2)
 ;;=^5002298
